Home > Compound List > Compound details
520-33-2 molecular structure
click picture or here to close

(2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one

ChemBase ID: 965
Molecular Formular: C16H14O6
Molecular Mass: 302.27876
Monoisotopic Mass: 302.07903817
SMILES and InChIs

SMILES:
O1[C@@H](CC(=O)c2c1cc(O)cc2O)c1cc(O)c(OC)cc1
Canonical SMILES:
COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O1)cc(cc2O)O
InChI:
InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1
InChIKey:
AIONOLUJZLIMTK-AWEZNQCLSA-N

Cite this record

CBID:965 http://www.chembase.cn/molecule-965.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one
IUPAC Traditional name
hesperetin
Brand Name
Hesperin
Synonyms
Hesperetin
4'-Methoxy-3',5,7-trihydroxyflavanone
3',5,7-Trihydroxy-4'-methoxyflavanone
Cyanidanon 4'-Methyl Ether 1626
Hesperitin
YSO2
Hesperetin
Hesperetin
4'-甲氧基-3,5,7-三羟基黄烷酮
CAS Number
520-33-2
EC Number
208-290-2
MDL Number
MFCD00075646
Beilstein Number
309850
Merck Index
144670
PubChem SID
46507998
160964428
PubChem CID
72281
CHEBI ID
28230
CHEMBL
399121
Chemspider ID
65234
DrugBank ID
DB01094
KEGG ID
C01709
Unique Ingredient Identifier
Q9Q3D557F1
Wikipedia Title
Hesperetin

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 7.8617015  H Acceptors
H Donor LogD (pH = 5.5) 2.675566 
LogD (pH = 7.4) 2.5483763  Log P 2.6774368 
Molar Refractivity 77.753 cm3 Polarizability 29.8365 Å3
Polar Surface Area 96.22 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 2.52  LOG S -3.34 
Solubility (Water) 1.38e-01 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Product Information Bioassay(PubChem)
Solubility
273 mg/L expand Show data source
Sol. EtOH, alkalis expand Show data source
Apperance
Powder expand Show data source
Melting Point
226–228 °C expand Show data source
227-232°C expand Show data source
Hydrophobicity(logP)
1.1 expand Show data source
Storage Condition
-20°C expand Show data source
European Hazard Symbols
Irritant Irritant (Xi) expand Show data source
Risk Statements
36/37/38 expand Show data source
Safety Statements
26-37 expand Show data source
TSCA Listed
expand Show data source
GHS Pictograms
GHS07 expand Show data source
GHS Hazard statements
H315-H319-H335 expand Show data source
GHS Precautionary statements
P261-P305+P351+P338-P302+P352-P321-P405-P501A expand Show data source
Purity
97% expand Show data source
Salt Data
Free Base expand Show data source

DETAILS

DETAILS

DrugBank DrugBank Selleck Chemicals Selleck Chemicals Wikipedia Wikipedia
DrugBank - DB01094 external link
Item Information
Drug Groups approved
Description Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside hesperidin, is the predominant flavonoid in lemons and oranges.
Indication For lowering cholesterol and, possibly, otherwise favorably affecting lipids. In vitro research also suggests the possibility that hesperetin might have some anticancer effects and that it might have some anti-aromatase activity, as well as activity again.
Pharmacology Hesperetin is a cholesterol lowering flavanoid found in a number of citrus juices. It appears to reduce cholesteryl ester mass and inhibit apoB secretion by up to 80%. Hesperetin may have antioxidant, anti-inflammatory, anti-allergic, hypolipidemic, vasoprotective and anticarcinogenic actions.
Affected Organisms
Humans and other mammals
External Links
Wikipedia
PDRhealth
Selleck Chemicals - S2308 external link
Research Area: Cardiovascular Disease
Biological Activity:
Hesperetin is a bioflavonoid and, to be more specific, a flavanone. Hesperidin (a flavonone glycoside) is water-soluble due to the presence of the sugar part in its structure, so on ingestion it releases its aglycone, i.e, hesperetin. [1] Hesperetin is a citrus flavonoid that has been reported to lower plasma cholesterol. It inhibits histamine release from IgE-challenged RBL-2H3 cells, with a potency comparable to the commercial anti-allergy drug azelastine. It also reduces the transcription of ACAT-2 mRNA in Hep-G2 cells and reduces ApoB protein synthesis in a dose-dependent manner. The EC50 for these responses is approximately 50 μM. [2][3]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle